SGLT2 inhibitors include canagliflozin, dapagliflozin and empagliflozin alone or in combination with metformin, which are authorised for the treatment of type 2 diabetes mellitus.
Home » Tag Archives: Empagliflozin
Tag Archives: Empagliflozin
Synjardy ▼
Company: Boehringer Ingelheim Ltd.
Jardiance ▼ – Approved for Treatment of Type 2 Diabetes
Download PDF Boehringer Ingelheim Ireland Ltd.
Jardiance ▼
Company: Boehringer Ingelheim Ltd.